Haematopoietic stem cell transplantation (HSCT) is an intense chemotherapy treatment for MS. It aims to stop the damage MS causes by wiping out and then regrowing your immune system, using your stem cells.
It can sometimes take years for research findings to be rolled out. The gap between clinical trials and the clinic means that people often miss out on services that were developed with them in mind. We're working to correct that.
Low vitamin D levels in newborns could increase their future risk of MS, according to new research. Scientists found that children born with very low levels of vitamin D were more likely to develop MS in later life.